Lost in Transition: The Essential Need for Long-Term Follow-Up Clinic for Blood and Marrow Transplantation Survivors

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 2, 2015, Pages 225-232

  Hashmi, Shahrukh ^a   Carpenter, Paul ^b   Khera, Nandita ^c   Tichelli, André ^d   Savani, Bipin N ^e  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e VANDERBILT UNIVERSITY   (United States)

Author keywords

Blood and marrow transplantation; Late effects; Survivorship clinic

Indexed keywords

ADMINISTRATIVE PERSONNEL; ADULT; ADULTHOOD; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER SCREENING; CANCER SURVIVAL; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL PRACTICE; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; GERIATRIC ASSESSMENT; GRAFT SURVIVAL; GROUPS BY AGE; HEALTH CARE NEED; HEMATOLOGIST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTERNATIONAL COOPERATION; INTERNIST; LABORATORY PERSONNEL; MALE; MEDICAL ETHICS; MIDDLE AGED; NONMYELOABLATIVE CONDITIONING; OCCUPATIONAL THERAPIST; ONCOLOGIST; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHYSIOTHERAPIST; PREVENTIVE HEALTH SERVICE; PRIMARY MEDICAL CARE; RADIOLOGIST; REDUCED INTENSITY CONDITIONING; REVIEW; REWARD; SURVIVOR; YOUNG ADULT; ADVERSE EFFECTS; AGED; CATARACT; CHILD; CHRONIC DISEASE; ECONOMIC MODEL; ECONOMICS; GRAFT VS HOST DISEASE; HEALTH SERVICE; HEMATOLOGIC NEOPLASMS; HOSPITAL; HYPOTHYROIDISM; MANPOWER; METABOLIC SYNDROME X; ORGANIZATION AND MANAGEMENT; PATHOLOGY; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES;

ADULT; AGED; BONE MARROW TRANSPLANTATION; CATARACT; CHILD; CHRONIC DISEASE; GRAFT VS HOST DISEASE; HEALTH SERVICES NEEDS AND DEMAND; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITALS, SPECIAL; HUMANS; HYPOTHYROIDISM; METABOLIC SYNDROME X; MODELS, ECONOMIC; STRESS DISORDERS, POST-TRAUMATIC; SURVIVORS; UNITED STATES;

EID: 84920987126     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.06.035     Document Type: Review

References (69)

1. Hewitt M., Greenfield S., Stovall E., et al. From cancer patient to cancer survivor: lost in transition 2006, National Academies Press, Washington DC, Available at:, Accessed on January 31, 2011. http://www.iom.edu/Reports/2005/From-Cancer-Patient-to-Cancer-Survivor-Lost-in-Transition.aspx.
2. Gooley T.A., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. NEng J Med 2010, 363:2091-2101.
3. HCT Trends and Survival Data. Available at:. Accessed March2014. http://www.cibmtr.org/ReferenceCenter/SlidesReports/SummarySlides/pages/index.aspx.
4. Majhail N.S., et al. Prevalence of hematopoietic cell transplant survivors in the United States. Biol Blood Marrow Transplant 2013, 19:1498-1501.
5. Baker K.S., Gurney J.G., Ness K.K., et al. Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study. Blood 2004, 104:1898-1906.
6. Hamilton J.G., Wu L., Austin J.E. Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology 2013, 22:911-921.
7. Wettergren L., et al. Post-traumatic stress symptoms in patients undergoing autologous stem cell transplantation. Acta Oncologica 1999, 38:475-480.
8. Stuber M.L., et al. Stress responses after pediatric bone marrow transplantation: Preliminary results of a prospective longitudinal study. JAm Acad Child Adolesc Psychiatry 1991, 30:952-957.
9. Lishner M., Patterson B., Kandel R., et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990, 65:473-476.
10. Leisenring W., Friedman D.L., Flowers M.E., et al. Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation. JClin Oncol 2006, 24:1119-1126.
11. Majhail N.S., Ness K.K., Burns L.J., et al. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant 2007, 13:1153-1159.
12. Annaloro C., et al. Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation. Bone Marrow Transplant 2008, 41:797-804.
13. Griffith M.L., Savani B.N., Boord J.B. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management. Blood 2010, 16:1197-1204.
14. Chow E.J., Baker K.S., Lee S.J., et al. Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation. JClin Oncol 2014, 32:191-198.
15. Majhail N.S., et al. Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning. Blood 2011, 117:316-322.
16. Tichelli A., Labopin M., Rovó A., et al. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer 2013, 119:2012-2021.
17. Ando M., Ohashi K., Akiyama H., et al. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant 2010, 25:278-282.
18. Le Meignen M., Auquier P., Barlogis V., et al. Bone mineral density in adult survivors of childhood acute leukemia: impact of hematopoietic stem cell transplantation and other treatment modalities. Blood 2011, 118:1481-1489.
19. Yao S., Smiley S.L., West K., et al. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:1130-1137.
20. Socié G., Henry-Amar M., Bacigalupo A., et al. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. NEngl J Med 1993, 329:1152-1157.
21. Deeg H.J., Socié G., Schoch G., et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996, 87:386-392.
22. Hammond C., Abrams J.R., Syrjala K.L. Fertility and risk factors for elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. JClin Oncol 2007, 25:3511-3517.
23. Tichelli A., Rovó A. Fertility issues following hematopoietic stem cell transplantation. Expert Rev Hematol 2013, 6:375-388.
24. Sanders J.E., et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996, 87:3045-3052.
25. Majhail N.S., DeFor T., Lazarus H.M., Burns L.J. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Biol Blood Marrow Transplant 2008, 14:790-794.
26. Pullarkat V., Blanchard S., Tegtmeier B., et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2008, 42:799-805.
27. Richardson M.A., Sanders T., Palmer J.L., et al. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. JClin Oncol 2000, 18:2505-2514.
28. Swarup A.B., Barrett W., Jazieh A.R. The use of complementary and alternative medicine by cancer patients undergoing radiation therapy. Am J Clin Oncol 2006, 29:468-473.
29. Kessler R.C., Davis R.B., Foster D.F., et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001, 135:262-268.
30. Blood and marrow transplantation long-term management: prevention and complications 2013, Wiley-Blackwell. B.N. Savani (Ed.).
31. Mohty M., Apperley J.F. Long-term physiological side effects after allogeneic bone marrow transplantation. Hematology Am Soc Hematol Educ Program 2010, 2010:229-236.
32. Majhail N.S., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012, 47:337-341.
33. Bishop M.M., Beaumont J.L., Hahn E.A., et al. Late effects of cancer and hematopoietic stem-cell transplantation on spouses or partners compared with survivors and survivor-matched controls. JClin Oncol 2007, 25:1403-1411.
34. Beattie S., Lebel S. The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review. Psychooncology 2011, 20:1137-1150.
35. Langer S.L., et al. Marital adjustment, satisfaction and dissolution among hematopoietic stem cell transplant patients and spouses: a prospective, five-year longitudinal investigation. Psychooncology 2010, 19:190-200.
36. Andrykowski M.A., Bishop M.M., Hahn E.A., et al. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. JClin Oncol 2005, 23:599-608.
37. Lee S.J., et al. Quality of life associated with acute and chronic graft-versus-host disease. Bone Marrow Transplant 2006, 38:305-310.
38. Pidala J., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
39. Syrjala K.L., Dikmen S., Langer S.L., et al. Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood 2004, 104:3386-3392.
40. Perkins J.L., Kunin-Batson A.S., Youngren N.M., et al. Long-term follow-up of children who underwent hematopoietic cell transplant (HCT) for AML or ALL at less than 3 years of age. Pediatr Blood Cancer 2007, 49:958-963.
41. Rusiewicz A., DuHamel K.N., Burkhalter J., et al. Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology 2008, 17:329-337.
42. Grunfeld E., Earle C.C. The interface between primary and oncology specialty care: treatment through survivorship. JNatl Cancer Inst Monogr 2010, 2010:25-30.
43. Shankar S.M., Carter A., Sun C.L., et al. Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study. Cancer Epidemiol Biomarkers Prev 2007, 16:834-839.
44. Roth J.A., et al. Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancer. JComp Eff Res 2014, 3:135-144.
45. Brown-Iannuzzi J.L., et al. Objective and subjective socioeconomic status and health symptoms in patients following hematopoietic stem cell transplantation. Psychooncology 2014, 23:740-748.
46. Thomas E.D., Lochte H.L., Cannon J.H., et al. Supralethal whole body irradiation and isologous marrow transplantation in man. JClin Invest 1959, 38:1709-1716.
47. Long-Term Follow-Up Guidelines. Available at:. Accessed April2014. http://www.survivorshipguidelines.org/pdf/LTFUGuidelines.pdf.
48. Majhail N.S., et al. Allogeneic transplant physician and center capacity in the United States. Biol Blood Marrow Transplant 2011, 17:956-961.
49. Burns L.J., et al. Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: The National Marrow Donor Program's System Capacity Initiative Physician Workforce Group Report. Biol Blood Marrow Transplant 2014, 20:617-621.
50. Virgo K.S., et al. Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. JClin Oncol 2013, 31:2322-2336.
51. American Society of Clinical Oncology: Chemotherapy treatment plans. Available at:. Accessed April2014. http://www.asco.org/quality-guidelines/chemotherapy-treatment-plan-and-summaries.
52. Jagasia M., Clifton C., Vaughan L., et al. Impact of longitudinal long-term transplant clinic (LTTC) on survival after allogeneic stem cell transplant (SCT). Biol Blood Marrow Transplant 2008, 14(Supp):107.
53. Ragon B.K., et al. Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy. Biol Blood Marrow Transplant 2014, 20:53-57.
54. Moyer V.A. U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 156:880-891.
55. Goldie S.J., et al. Cost-effectiveness of cervical-cancer screening in five developing countries. NEng J Med 2005, 353:2158-2168.
56. Sonnenberg A., Delco F., Inadomi J.M. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000, 133:573-584.
57. Screening for Lung Cancer, Current Recommendations. Available at:. Accessed April2014. http://www.uspreventiveservicestaskforce.org/uspstf/uspslung.htm.
58. West S., Sommer A. Prevention of blindness and priorities for the future. Bull World Health Organ 2001, 79:244-248.
59. Thylefors B. Aglobal initiative for the elimination of avoidable blindness. Community Eye Health 1998, 11:1-3.
60. Baltussen R., Sylla M., Mariotti S.P. Cost-effectiveness analysis of cataract surgery: a global and regional analysis. Bull World Health Organ 2004, 82:338-345.
61. Wojciechowski E.A., Hurtig A., Dorn L. Anatural history study of adolescents and young adults with sickle cell disease as they transfer to adult care: a need for case management services. JPediatr Nursing 2002, 17:18-27.
62. Tuchman L.K., Slap G.B., Britto M.T. Transition to adult care: experiences and expectations of adolescents with a chronic illness. Child Care Health Dev 2008, 34:557-563.
63. Ginsberg J.P., et al. Delivering long-term follow-up care to pediatric cancer survivors: transitional care issues. Pediatr Blood Cancer 2006, 46:169-173.
64. Sudore R.L., Fried T.R. Redefining the "planning" in advance care planning: preparing for end-of-life decision making. Ann Intern Med 2010, 153:256-261.
65. Keeler E.B., Robalino D.A., Frank J.C., et al. Cost-effectiveness of outpatient geriatric assessment with an intervention to increase adherence. Med Care 1999, 37:1199-1206.
66. Gratwohl A., et al. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010, 303:1617-1624.
67. Budiani-Saberi D.A., Delmonico F.L. Organ trafficking and transplant tourism: a commentary on the global realities. Am J Transplant 2008, 8:925-929.
68. Khera N., Zeliadt S.B., Lee S.J. Economics of hematopoietic cell transplantation. Blood 2012, 120:1545-1551.
69. Sakhuja V., Sud K. End-stage renal disease in India and Pakistan: burden of disease and management issues. Kidney Int Suppl 2003, S115-S118.